Patents by Inventor Padma Narayan

Padma Narayan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NIRAPARIB FORMULATIONS
    Publication number: 20240082231
    Abstract: The present invention relates to pharmaceutical tablet compositions comprising the compound niraparib as an active pharmaceutical ingredient, suitable for oral administration as well as to methods for their preparation. Also described herein are tablet compositions containing niraparib formed by the disclosed methods, and therapeutic uses of such tablet compositions for treating various disorders and conditions.
    Type: Application
    Filed: June 23, 2023
    Publication date: March 14, 2024
    Inventors: Simon McGurk, Padma Narayan, Aleksandar Rajlic
  • FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF
    Publication number: 20230285417
    Abstract: This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and pharmaceutical compositions thereof. Also disclosed herein are methods of making the pharmaceutical compositions of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
    Type: Application
    Filed: July 20, 2021
    Publication date: September 14, 2023
    Inventors: Paul Steven Watson, Bret Berner, Padma Narayan, Xiaoxia Chen, Todd Anthony Stutzman, Jianing Meng, Carolyn Wilkerson, Raj Ramnik Jain
  • Niraparib formulations
    Patent number: 11730725
    Abstract: The present invention relates to pharmaceutical tablet compositions comprising the compound niraparib as an active pharmaceutical ingredient, suitable for oral administration as well as to methods for their preparation. Also described herein are tablet compositions containing niraparib formed by the disclosed methods, and therapeutic uses of such tablet compositions for treating various disorders and conditions.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: August 22, 2023
    Assignee: Tesaro, Inc.
    Inventors: Simon McGurk, Padma Narayan, Aleksandar Rajlic
  • FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF
    Publication number: 20230057130
    Abstract: This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and pharmaceutical compositions thereof. Also disclosed herein are methods of making the pharmaceutical compositions of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
    Type: Application
    Filed: January 19, 2022
    Publication date: February 23, 2023
    Inventors: Paul Steven Watson, Bret Berner, Padma Narayan, Xiaoxia Chen, Todd Anthony Stutzman, Jianing Meng, Carolyn Wilkerson, Raj Ramnik Jain
  • NIRAPARIB FORMULATIONS
    Publication number: 20210038585
    Abstract: The present invention relates to pharmaceutical capsule compositions comprising the compound niraparib as an active pharmaceutical ingredient, suitable for oral administration as well as to methods for their preparation. Also described herein are capsule formulations containing niraparib formed by the disclosed methods, and therapeutic uses of such capsule formulations for treating various disorders and conditions. The niraparib is distributed with substantial uniformity throughout a pharmaceutically acceptable carrier of the capsule formulations and exhibit good long-term stability and dissolution properties.
    Type: Application
    Filed: October 16, 2020
    Publication date: February 11, 2021
    Inventors: Simon McGurk, Padma Narayan, Clare Medendorp, George Wu, Stephen Ruddy, Heidi Kempinski, Alistair Stewart
  • NIRAPARIB FORMULATIONS
    Publication number: 20200289494
    Abstract: The present invention relates to pharmaceutical tablet compositions comprising the compound niraparib as an active pharmaceutical ingredient, suitable for oral administration as well as to methods for their preparation. Also described herein are tablet compositions containing niraparib formed by the disclosed methods, and therapeutic uses of such tablet compositions for treating various disorders and conditions.
    Type: Application
    Filed: September 26, 2018
    Publication date: September 17, 2020
    Inventors: Simon McGurk, Padma Narayan, Aleksandar Rajlic
  • NIRAPARIB FORMULATIONS
    Publication number: 20200016142
    Abstract: The present invention relates to pharmaceutical capsule compositions comprising the compound niraparib as an active pharmaceutical ingredient, suitable for oral administration as well as to methods for their preparation. Also described herein are capsule formulations containing niraparib formed by the disclosed methods, and therapeutic uses of such capsule formulations for treating various disorders and conditions. The niraparib is distributed with substantial uniformity throughout a pharmaceutically acceptable carrier of the capsule formulations and exhibit good long-term stability and dissolution properties.
    Type: Application
    Filed: September 26, 2019
    Publication date: January 16, 2020
    Inventors: Simon McGurk, Padma Narayan, Clare Medendorp, George Wu, Stephen Ruddy, Heidi Kempinski, Alistair Stewart